Sutro Biopharma, Inc.
STRO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001382101
No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Sutro Biopharma, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 117 | 119 | +2 |
| Shares | 53.4M | 63.2M | +9.76M (+18.3%) |
| Value | $301.7M | $185.1M | −$116.6M (−38.7%) |
New holders (21)
Institutions that held Sutro Biopharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 235,397 | $690.0K | 0.05% |
| LPL Financial LLC | 230,149 | $674.3K | 0.00% |
| Franklin Resources Inc | 95,423 | $279.6K | 0.00% |
| Qube Research & Technologies Ltd | 70,614 | $206.9K | 0.00% |
| Alps Advisors Inc | 63,785 | $186.9K | 0.00% |
| Hudson Bay Capital Management LP | 60,761 | $178.0K | 0.00% |
| Corebridge Financial, Inc. | 44,040 | $129.0K | 0.00% |
| Nomura Holdings Inc | 43,426 | $127.2K | 0.00% |
| Squarepoint Ops LLC | 39,186 | $114.8K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 30,913 | $90.6K | 0.00% |
| Sherbrooke Park Advisers LLC | 19,073 | $55.9K | 0.01% |
| Arrowstreet Capital, Limited Partnership | 13,661 | $40.0K | 0.00% |
| BKD Wealth Advisors, LLC | 12,840 | $37.6K | 0.00% |
| State of Wyoming | 11,725 | $34.4K | 0.01% |
| Meeder Asset Management Inc | 2,822 | $8.27K | 0.00% |
| Group One Trading, L.P. | 1,100 | $3.22K | 0.00% |
| Gen-Wealth Partners Inc | 1,042 | $3.05K | 0.00% |
| SRS Capital Advisors, Inc. | 657 | $1.93K | 0.00% |
| Signaturefd, LLC | 354 | $1.04K | 0.00% |
| The PNC Financial Services Group, Inc. | 51 | $149 | 0.00% |
| Rothschild Investment LLC | 30 | $88 | 0.00% |
Sold out (19)
Institutions that held Sutro Biopharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 440,422 | $2.49M |
| Propel Bio Management, LLC | 195,000 | $1.10M |
| Simplify Asset Management Inc. | 120,000 | $678.0K |
| Jump Financial, LLC | 111,197 | $628.3K |
| EntryPoint Capital, LLC | 69,678 | $393.7K |
| Lighthouse Investment Partners, LLC | 66,585 | $376.2K |
| Virtu Financial LLC | 63,157 | $357.0K |
| Chase Investment Counsel Corp | 57,700 | $326.0K |
| Mirae Asset Global Investments Co., Ltd. | 44,019 | $202.5K |
| Kennedy Capital Management, Inc. | 30,947 | $174.9K |
| American International Group, Inc. | 30,017 | $169.6K |
| Two Sigma Securities, LLC | 23,291 | $131.6K |
| Deerfield Management Company, L.P. (Series C) | 16,925 | $95.6K |
| Lazard Asset Management LLC | 16,386 | $92.0K |
| HRT Financial LP | 12,057 | $68.0K |
| Quantbot Technologies LP | 2,100 | $11.9K |
| Metropolitan Life Insurance Co | 1,632 | $9.22K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 285 | $1.61K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $73 |